{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:25:28Z","timestamp":1794435928879,"version":"4.9.1"},"reference-count":120,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002703","name":"Jiangsu University","doi-asserted-by":"publisher","award":["JDYY2023004"],"award-info":[{"award-number":["JDYY2023004"]}],"id":[{"id":"10.13039\/501100002703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018588","name":"Yibin Science and Technology Planning Program","doi-asserted-by":"publisher","award":["jdfyRC2017003"],"award-info":[{"award-number":["jdfyRC2017003"]}],"id":[{"id":"10.13039\/501100018588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018588","name":"Yibin Science and Technology Planning Program","doi-asserted-by":"publisher","award":["BGYCB202203"],"award-info":[{"award-number":["BGYCB202203"]}],"id":[{"id":"10.13039\/501100018588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.heliyon.2024.e38831","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T19:34:35Z","timestamp":1727811275000},"page":"e38831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Blood hypercoagulability and thrombosis mechanisms in cancer patients -A brief review"],"prefix":"10.1016","volume":"10","author":[{"given":"Qiongle","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e38831_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","article-title":"Cancer-associated venous thromboembolism","volume":"8","author":"Khorana","year":"2022","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.heliyon.2024.e38831_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"Khan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2024.e38831_bib3","article-title":"Lectures on clinical medicine, lindsay & blakiston","author":"Trousseau","year":"1873","journal-title":"Population (Paris)"},{"key":"10.1016\/j.heliyon.2024.e38831_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/OTT.S281251","article-title":"Aberrant factors of fibrinolysis and coagulation in pancreatic cancer","volume":"14","author":"Fang","year":"2021","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.heliyon.2024.e38831_bib5","doi-asserted-by":"crossref","first-page":"V215","DOI":"10.1016\/S0049-3848(01)00285-7","article-title":"Molecular basis for the relationship between thrombosis and cancer","volume":"102","author":"Rickles","year":"2001","journal-title":"Thromb. Res."},{"key":"10.1016\/j.heliyon.2024.e38831_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jth.12075","article-title":"Coagulation and cancer: biological and clinical aspects","volume":"11","author":"Falanga","year":"2013","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.heliyon.2024.e38831_bib7","article-title":"Label-free biophysical markers from whole blood microfluidic immune profiling reveal severe immune response signatures","volume":"17","author":"Zeming","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.heliyon.2024.e38831_bib8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41416-022-02072-2","article-title":"Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer","volume":"128","author":"Yazaki","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e38831_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb4639","article-title":"An implantable blood clot\u2013based immune niche for enhanced cancer vaccination","volume":"6","author":"Fan","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.heliyon.2024.e38831_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11239-021-02621-1","article-title":"Global coagulation assays in hypercoagulable states","volume":"54","author":"Lim","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.heliyon.2024.e38831_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","article-title":"Therapeutic strategies for thrombosis: new targets and approaches","volume":"19","author":"Mackman","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.heliyon.2024.e38831_bib12","first-page":"590","article-title":"Risk factors of arterial events in patients with venous thromboembolism: a systematic review and meta-analysis","volume":"122","author":"Noumegni","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.heliyon.2024.e38831_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11239-022-02662-0","article-title":"Tissue factor: a neglected role in cancer biology","volume":"54","author":"Li","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.heliyon.2024.e38831_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1702","article-title":"Cancer-associated-platelet-inspired nanomedicines for cancer therapy","volume":"13","author":"Geranpayehvaghei","year":"2021","journal-title":"WIREs Nanomedicine and Nanobiotechnology"},{"key":"10.1016\/j.heliyon.2024.e38831_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117690","article-title":"Tumor-educated platelets","volume":"552","author":"Najafi","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.heliyon.2024.e38831_bib16","first-page":"619","article-title":"Common pathophysiology in cancer, atrial fibrillation, atherosclerosis, and thrombosis","volume":"3","author":"Leiva","year":"2021","journal-title":"JACC (J. Am. Coll. Cardiol.): CardioOncology"},{"key":"10.1016\/j.heliyon.2024.e38831_bib17","first-page":"468","article-title":"Exercise is medicine in oncology: engaging clinicians to help patients move through cancer","volume":"69","author":"Schmitz","year":"2019","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.heliyon.2024.e38831_bib18","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/bmj.320.7247.1453","article-title":"ABC of arterial and venous disease. Swollen lower limb-1: general assessment and deep vein thrombosis","volume":"320","author":"Gorman","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2024.e38831_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/rth2.12469","article-title":"Visualizing thrombosis to improve thrombus resolution","volume":"5","author":"Weisel","year":"2021","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"key":"10.1016\/j.heliyon.2024.e38831_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202984","article-title":"Impact of fibrinogen, fibrin thrombi, and thrombin on cancer cell extravasation using in vitro microvascular networks","volume":"12","author":"Angelidakis","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.heliyon.2024.e38831_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100733","article-title":"Interplay between platelets and coagulation","volume":"46","author":"Sang","year":"2021","journal-title":"Blood Rev."},{"key":"10.1016\/j.heliyon.2024.e38831_bib22","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e38831_bib23","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1021\/acsnano.2c11965","article-title":"Advances in drug delivery systems based on red blood cells and their membrane-derived nanoparticles","volume":"17","author":"Nguyen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.heliyon.2024.e38831_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.trecan.2021.12.008","article-title":"Coagulome and the tumor microenvironment: an actionable interplay","volume":"8","author":"Galmiche","year":"2022","journal-title":"Trends in Cancer"},{"key":"10.1016\/j.heliyon.2024.e38831_bib25","doi-asserted-by":"crossref","DOI":"10.1148\/rg.2020190097","article-title":"Venous thrombosis and hypercoagulability in the abdomen and pelvis: causes and imaging findings","volume":"40","author":"Olson","year":"2020","journal-title":"Radiographics"},{"key":"10.1016\/j.heliyon.2024.e38831_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ajh.26440","article-title":"Increased blood viscosity and red blood cell aggregation in patients with COVID-19","volume":"97","author":"Nader","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31201","article-title":"Hemostatic alterations in patients with cirrhosis: from primary hemostasis to fibrinolysis","volume":"71","author":"Zermatten","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2024.e38831_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9149(01)01509-0","article-title":"Angiotensin, fibrinolysis, and vascular homeostasis","volume":"87","author":"Vaughan","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib29","series-title":"Biomolecules","article-title":"Imbalance in coagulation\/fibrinolysis inhibitors resulting in extravascular thrombin generation in gliomas of varying levels of malignancy","author":"Wojtukiewicz","year":"2021"},{"key":"10.1016\/j.heliyon.2024.e38831_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102322","article-title":"Interplay between coagulation and inflammation in cancer: limitations and therapeutic opportunities","volume":"102","author":"Bauer","year":"2022","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.heliyon.2024.e38831_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12951-023-01825-2","article-title":"Theranostic applications of selenium nanomedicines against lung cancer","volume":"21","author":"Liu","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib32","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.ejso.2020.11.276","article-title":"Risk of post-operative venous thromboembolism after surgery for colorectal malignancy: a systematic review and meta-analysis","volume":"47","author":"Lewis-Lloyd","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/cnr2.1742","article-title":"The burden and predictors of venous thromboembolic diseases in patients with multiple primary malignancies","volume":"6","author":"Alhamadh","year":"2023","journal-title":"Cancer Reports"},{"key":"10.1016\/j.heliyon.2024.e38831_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120297","article-title":"Nanomedicine progress in thrombolytic therapy","volume":"258","author":"Zenych","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.heliyon.2024.e38831_bib35","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/BOT.0000000000001714","article-title":"Ability of thromboelastography to detect hypercoagulability: a systematic review and meta-analysis","volume":"34","author":"Brown","year":"2020","journal-title":"J. Orthop. Trauma"},{"key":"10.1016\/j.heliyon.2024.e38831_bib36","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/lary.30417","article-title":"Perioperative hypercoagulability in free flap reconstructions performed for intracranial tumors","volume":"133","author":"Lilly","year":"2023","journal-title":"Laryngoscope"},{"key":"10.1016\/j.heliyon.2024.e38831_bib37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41467-023-44231-w","article-title":"Quick model-based viscoelastic clot strength predictions from blood protein concentrations for cybermedical coagulation control","volume":"15","author":"Ghetmiri","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e38831_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2023.133873","article-title":"Rapid microfluidic-thromboelastography (\u03bc-TEG) for evaluating whole blood coagulation and fibrinolysis at elevated shear rates","volume":"390","author":"Wang","year":"2023","journal-title":"Sensor. Actuator. B Chem."},{"key":"10.1016\/j.heliyon.2024.e38831_bib39","article-title":"Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.heliyon.2024.e38831_bib40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/CORR.0000000000002314","article-title":"What proportion of patients with musculoskeletal tumors demonstrate thromboelastographic markers of hypercoagulability? A pilot study","volume":"481","author":"Sabharwal","year":"2023","journal-title":"Clinical Orthopaedics and Related Research\u00ae"},{"key":"10.1016\/j.heliyon.2024.e38831_bib41","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1111\/cas.15106","article-title":"Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancer","volume":"112","author":"Kobayashi","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.heliyon.2024.e38831_bib42","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2019.236901","article-title":"Fibrin(ogen) in human disease: both friend and foe","volume":"105","author":"Rui","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.heliyon.2024.e38831_bib43","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib44","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.neo.2020.09.006","article-title":"Injured tissues favor cancer cell implantation via fibrin deposits on scar zones","volume":"22","author":"Al dybiat","year":"2020","journal-title":"Neoplasia"},{"key":"10.1016\/j.heliyon.2024.e38831_bib45","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.3390\/ijms23136981","article-title":"Immunohistochemical profile of parathyroid tumours: a comprehensive review","author":"Uljanovs","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e38831_bib46","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1182\/blood.2020005819","article-title":"Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis","volume":"136","author":"Mulder","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e38831_bib47","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1182\/blood-2019-128170","article-title":"Outcomes of patients receiving direct oral anticoagulants for myeloproliferative neoplasm associated venous thromboembolism","volume":"134","author":"Doyle","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e38831_bib48","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/s41375-020-0890-1","article-title":"Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study","volume":"34","author":"Crodel","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.heliyon.2024.e38831_bib49","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1111\/bjh.16485","article-title":"Outcomes of patients receiving direct oral anticoagulants for myeloproliferative neoplasm-associated venous thromboembolism in a large tertiary centre in the UK","volume":"189","author":"Curto-Garcia","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29522","article-title":"Markers of hypercoagulability in children with newly diagnosed acute lymphoblastic leukemia","volume":"69","author":"Carmona","year":"2022","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.heliyon.2024.e38831_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102162","article-title":"Thromboembolism in nephrotic syndrome: controversies and uncertainties","volume":"7","author":"Parker","year":"2023","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"key":"10.1016\/j.heliyon.2024.e38831_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111561","article-title":"Pharmacological and clinical application of heparin progress: an essential drug for modern medicine","volume":"139","author":"Qiu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e38831_bib53","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/jth.14773","article-title":"Plasmin\u2010mediated proteolysis of human factor IXa in the presence of calcium\/phospholipid: conversion of procoagulant factor IXa to a fibrinolytic enhancer","volume":"18","author":"Schmidt","year":"2020","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.heliyon.2024.e38831_bib54","series-title":"Thrombosis and Hemostasis in Cancer","first-page":"11","article-title":"Pathophysiology 1. Mechanisms of thrombosis in cancer patients","author":"Falanga","year":"2019"},{"key":"10.1016\/j.heliyon.2024.e38831_bib55","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1038\/s41388-022-02511-7","article-title":"Integrin regulation by tissue factor promotes cancer stemness and metastatic dissemination in breast cancer","volume":"41","author":"Unlu","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2024.e38831_bib56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10930-018-9758-x","article-title":"In vitro screening of synthetic fluorogenic substrates for detection of cancer procoagulant activity","volume":"37","author":"Krause","year":"2018","journal-title":"Protein J."},{"key":"10.1016\/j.heliyon.2024.e38831_bib57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-022-01683-w","article-title":"Circulating biosignatures in multiple myeloma and their role in multidrug resistance","volume":"22","author":"Krishnan","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.heliyon.2024.e38831_bib58","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3343\/alm.2018.38.3.274","article-title":"Circulating microparticles and coagulation profiles in patients with advanced stage solid tumors","volume":"38","author":"Lee","year":"2018","journal-title":"Annals of Laboratory Medicine"},{"key":"10.1016\/j.heliyon.2024.e38831_bib59","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s12276-021-00688-7","article-title":"Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs","volume":"53","author":"Seo","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e38831_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094358","article-title":"Fibrinolytic system and cancer: diagnostic and therapeutic applications","author":"Mahmood","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e38831_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102536","article-title":"Phosphatidylserine: the unique dual-role biomarker for cancer imaging and therapy","author":"Kaynak","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e38831_bib62","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41419-020-03081-w","article-title":"The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis","volume":"11","author":"Wegwitz","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e38831_bib63","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/biom12020152","article-title":"The urokinase plasminogen activation system in pancreatic cancer: prospective diagnostic and therapeutic targets","author":"Kumar","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.heliyon.2024.e38831_bib64","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3390\/biom11121772","article-title":"The ANXA2\/S100A10 complex\u2014regulation of the oncogenic plasminogen receptor","author":"Bharadwaj","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.heliyon.2024.e38831_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.614726","article-title":"Alpha-Enolase: emerging tumor-associated antigen, cancer biomarker, and oncotherapeutic target","volume":"11","author":"Almaguel","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.heliyon.2024.e38831_bib66","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/bjc.2017.356","article-title":"TAMeless traitors: macrophages in cancer progression and metastasis","volume":"117","author":"Aras","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e38831_bib67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s12276-020-0397-x","article-title":"Therapeutics targeting the fibrinolytic system","volume":"52","author":"Lin","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e38831_bib68","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.3390\/ijms22052721","article-title":"A narrative review on plasminogen activator inhibitor-1 and its (patho)physiological role: to target or not to target?","author":"Sillen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e38831_bib69","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1038\/s41467-024-47516-w","article-title":"Platelets favor the outgrowth of established metastases","volume":"15","author":"Garcia-Leon","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e38831_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103969","article-title":"Circulating tumor cells: towards mechanical phenotyping of metastasis","volume":"25","author":"Peralta","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.heliyon.2024.e38831_bib71","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","article-title":"Neutrophils escort circulating tumour cells to enable cell cycle progression","volume":"566","author":"Szczerba","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e38831_bib72","first-page":"E3053","volume":"vol. 111","author":"Labelle","year":"2014"},{"key":"10.1016\/j.heliyon.2024.e38831_bib73","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","article-title":"The platelet lifeline to cancer: challenges and opportunities","volume":"33","author":"Haemmerle","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.heliyon.2024.e38831_bib74","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood.2023022928","article-title":"Procoagulant platelets promote immune evasion in triple-negative breast cancer","volume":"144","author":"Schaubaecher","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e38831_bib75","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1158\/2159-8290.CD-12-0329","article-title":"The initial hours of metastasis: the importance of cooperative host\u2013tumor cell interactions during hematogenous dissemination","volume":"2","author":"Labelle","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.heliyon.2024.e38831_bib76","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1182\/blood.2020005710","article-title":"Local blood coagulation drives cancer cell arrest and brain metastasis in a mouse model","volume":"137","author":"Feinauer","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e38831_bib77","doi-asserted-by":"crossref","first-page":"vi35","DOI":"10.1093\/annonc\/mdy319.002","article-title":"Plasminogen activator inhibitor-1 promotes immunosuppression in cancer by modulating immune component of tumor microenvironment","volume":"29","author":"Yadav","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib78","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12943-021-01347-1","article-title":"Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?","volume":"20","author":"Ward","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.heliyon.2024.e38831_bib79","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.canlet.2021.07.032","article-title":"Natural killer cells in cancer and cancer immunotherapy","volume":"520","author":"Raskov","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.heliyon.2024.e38831_bib80","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41392-022-01058-z","article-title":"Natural killer cell homing and trafficking in tissues and tumors: from biology to application","volume":"7","author":"Ran","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.heliyon.2024.e38831_bib81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.critrevonc.2017.08.003","article-title":"Mechanisms and risk factors of thrombosis in cancer","volume":"118","author":"Falanga","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01805","article-title":"Platelets, thrombo-inflammation, and cancer: collaborating with the enemy","volume":"10","author":"Palacios-Acedo","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10346","article-title":"C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation","volume":"7","author":"Bulla","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e38831_bib84","series-title":"Tumor Microenvironment and Cellular Stress","first-page":"229","article-title":"The role of complement in tumor growth","author":"Pio","year":"2014"},{"key":"10.1016\/j.heliyon.2024.e38831_bib85","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1172\/JCI90962","article-title":"The role of the complement system in cancer","volume":"127","author":"Afshar-Kharghan","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.heliyon.2024.e38831_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.593610","article-title":"How does complement affect hematological malignancies: from basic mechanisms to clinical application","volume":"11","author":"Luo","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib87","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13045-018-0669-2","article-title":"Role of platelets and platelet receptors in cancer metastasis","volume":"11","author":"Schlesinger","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00865","article-title":"Is the complement protein C1q a pro- or anti-tumorigenic factor? Bioinformatics analysis involving human carcinomas","volume":"10","author":"Mangogna","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.882298","article-title":"Distinct roles of classical and lectin pathways of complement in preeclamptic placentae","volume":"13","author":"Belmonte","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib90","first-page":"4209","volume":"vol. 111","author":"Bossi","year":"2014"},{"key":"10.1016\/j.heliyon.2024.e38831_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101642","article-title":"Complement activation in cancer: effects on tumor-associated myeloid cells and immunosuppression","volume":"60","author":"Magrini","year":"2022","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib92","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1182\/blood.2019003977","article-title":"Aspirin and antiplatelet treatments in cancer","volume":"137","author":"Tao","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e38831_bib93","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2024.e38831_bib94","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12885-018-4156-5","article-title":"Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies","volume":"18","author":"Qiao","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e38831_bib95","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1186\/s12885-020-07117-4","article-title":"Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis","volume":"20","author":"Lin","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e38831_bib96","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10654-023-00976-8","article-title":"Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women","volume":"38","author":"L\u00f8fling","year":"2023","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib97","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/bjs\/znad231","article-title":"Aspirin chemoprevention in colorectal cancer: network meta-analysis of low, moderate, and high doses","volume":"110","author":"Shah","year":"2023","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.heliyon.2024.e38831_bib98","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1172\/JCI121985","article-title":"Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1\/thromboxane A2","volume":"129","author":"Lucotti","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.heliyon.2024.e38831_bib99","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10555-017-9683-z","article-title":"Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?","volume":"36","author":"Wojtukiewicz","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.heliyon.2024.e38831_bib100","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0140-6736(17)30770-5","article-title":"Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study","volume":"390","author":"Li","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2024.e38831_bib101","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1245\/s10434-024-14938-1","article-title":"Absence of hypercoagulation status after neoadjuvant treatment is associated with favorable prognosis in patients undergoing subtotal esophagectomy for esophageal squamous cell carcinoma","volume":"31","author":"Sugiyama","year":"2024","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib102","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620954282","article-title":"Cancer-associated thrombosis: risk factors, molecular mechanisms, future management","volume":"26","author":"Hamza","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.heliyon.2024.e38831_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1342439","article-title":"Thromboelastogram and coagulation function index: relevance for female breast cancer","volume":"14","author":"Peng","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-03195-0","article-title":"DNA liquid biopsy-based prediction of cancer-associated venous thromboembolism","author":"Jee","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e38831_bib105","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1089\/ars.2021.0086","article-title":"Thiol isomerases orchestrate thrombosis and hemostasis","volume":"35","author":"Gaspar","year":"2021","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.heliyon.2024.e38831_bib106","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41416-022-01968-3","article-title":"Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications","volume":"127","author":"Koizume","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e38831_bib107","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017559","article-title":"Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.heliyon.2024.e38831_bib108","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.thromres.2023.08.012","article-title":"Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation","volume":"230","author":"Li","year":"2023","journal-title":"Thromb. Res."},{"key":"10.1016\/j.heliyon.2024.e38831_bib109","doi-asserted-by":"crossref","first-page":"S1127","DOI":"10.1016\/j.jtho.2021.08.554","article-title":"P53.05 inhibition of tumor cell intrinsic complement regulatory proteins leads to decreased tumor growth in a mouse model of NSCLC","volume":"16","author":"Kleczko","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110890","article-title":"Oncogenic pathways refine a new perspective on the classification of hepatocellular carcinoma","volume":"111","author":"Zhang","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.heliyon.2024.e38831_bib111","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/1076029618779136","article-title":"Association of genetic variability in selected genes in patients with deep vein thrombosis and platelet hyperaggregability","volume":"24","author":"Sokol","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.heliyon.2024.e38831_bib112","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1038\/s41598-022-12401-3","article-title":"The K-Ras(G12D)-inhibitory peptide KS-58 suppresses growth of murine CT26 colorectal cancer cell-derived tumors","volume":"12","author":"Sakamoto","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e38831_bib113","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1182\/blood.2022017697","article-title":"JAK2V617F allele burden in polycythemia vera: burden of proof","volume":"141","author":"Moliterno","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e38831_bib114","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.mattod.2022.02.010","article-title":"The interplay between hemostasis and immune response in biomaterial development for osteogenesis","volume":"54","author":"Xiao","year":"2022","journal-title":"Mater. Today"},{"key":"10.1016\/j.heliyon.2024.e38831_bib115","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/jth.15052","article-title":"Anticoagulant and signaling functions of antithrombin","volume":"18","author":"Rezaie","year":"2020","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.heliyon.2024.e38831_bib116","article-title":"Free flap reconstruction of scalp in a case of advanced lung cancer with brain metastasis: a case report","volume":"102","author":"Lee","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.heliyon.2024.e38831_bib117","doi-asserted-by":"crossref","first-page":"10583","DOI":"10.1182\/blood-2022-165673","article-title":"Validation of the gatmo score in predicting mortality following autologous hematopoietic cell transplant in multiple myeloma patients","volume":"140","author":"Awada","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e38831_bib118","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.beha.2008.12.001","article-title":"Epidemiology of cancer-related venous thromboembolism","volume":"22","author":"Wun","year":"2009","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.heliyon.2024.e38831_bib119","article-title":"Platelet cancer cell interplay as a new therapeutic target","volume":"1877","author":"Morris","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.heliyon.2024.e38831_bib120","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41568-019-0210-0","article-title":"Context-dependent roles of complement in cancer","volume":"19","author":"Roumenina","year":"2019","journal-title":"Nat. Rev. Cancer"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024148621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024148621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:02:34Z","timestamp":1789822954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024148621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":120,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2405844024148621"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38831","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood hypercoagulability and thrombosis mechanisms in cancer patients -A brief review","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e38831"}}